Clinical trial · Observational
Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language
NCT03632811CI-TRIAL-00039525Mc_QoLcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Mastocytosis is a heterogeneous rare disease. A 27-item questionnaire to assess the quality of life of patients with cutaneous/ indolent systemic mastocytosis was developed in the German language and validated in the English language in 2015. The team of the University Charité Berlin and the company Moxie - intellectual proprietor of the questionnaire - proposed the use of the recommendations of Baiardini et al. 2010, for linguistic adaptation of this questionnaire in other languages.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cutaneous Mastocytosis | Cutaneous Mastocytosis | ONTOLOGY_EXACT | 0.98 |
| Indolent Systemic Mastocytosis | Indolent Systemic Mastocytosis | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| A structured interview with every patient | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (4)
- measure
- The understanding of aspects of the questionnaire Mc-QoL
- timeFrame
- 1 day
- description
- The understanding of aspects of the questionnaire Mc-QoL (version "secondary" in French) will be evaluated for each patient: \- the instructions
- measure
- The understanding of aspects of the questionnaire Mc-QoL
- timeFrame
- 1 day
- description
- The understanding of aspects of the questionnaire Mc-QoL (version "secondary" in French) will be evaluated for each patient : \- the questions (items) and the proposed answers
- measure
- The understanding of aspects of the questionnaire Mc-QoL
- timeFrame
- 1 day
- description
- The understanding of aspects of the questionnaire Mc-QoL (version "secondary" in French) will be evaluated for each patient : \- the layout of the questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult, native French patient with cutaneous or indolent systemic mastocytosis and follow-up at CEREMAST, Toulouse * Patient having given his agreement of non-opposition Exclusion Criteria: * Minor patient * Patient with other forms of mast cell pathology except cutaneous and / or indolent systemic mastocytosis * Patient with no mast cell pathology * French non-native patient * Patient in detention or under guardianship * Patient not affiliated with Social Security
References
Publications (0)
Data not yet available
No reference posted for this study.